Search alternatives:
significant cases » significant cause (Expand Search), significant based (Expand Search), significant changes (Expand Search)
changes decrease » change increases (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
cases based » case based (Expand Search), scores based (Expand Search), values based (Expand Search)
Showing 41 - 60 results of 45,959 for search '(( significant cases based ) OR ( significant ((changes decrease) OR (larger decrease)) ))', query time: 0.95s Refine Results
  1. 41
    Significant changes in whole-brain voxelwise analysis.

    Significant changes in whole-brain voxelwise analysis. by José V. Pardo (8293983)

    Published 2020
    Save to List
    Saved in:
  2. 42
    Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue.

    Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue. by Jian-Bin Yin (19556105)

    Published 2024
    Save to List
    Saved in:
  3. 43
    Values of changes in cytokine and some biomarkers levels for prediction of mortality in COVID-19 cases.

    Values of changes in cytokine and some biomarkers levels for prediction of mortality in COVID-19 cases. by Hasan Selcuk Ozger (11785143)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 44
    Percentage of US adults with health insurance coverage by income-level, age 60 to 70 years.

    Percentage of US adults with health insurance coverage by income-level, age 60 to 70 years. by Rahul Aggarwal (4428457)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 45
    Significant genes identified in the gene-based test with GWAS summary data.

    Significant genes identified in the gene-based test with GWAS summary data. by Samantha Gonzales (8798435)

    Published 2025
    Save to List
    Saved in:
  6. 46
    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab.

    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 47
    Number of significant genes and fold change.

    Number of significant genes and fold change. by Gordon A. Barr (11163243)

    Published 2023
    Save to List
    Saved in:
  8. 48
    Significant main effect of age showing decreased gray matter volume in nearly the entire cortical brain and subcortical cortex.

    Significant main effect of age showing decreased gray matter volume in nearly the entire cortical brain and subcortical cortex. by Zhiliang Long (306092)

    Published 2020
    Save to List
    Saved in:
  9. 49
    T-test statistical significance results.

    T-test statistical significance results. by Ahmed Hamza Osman (10189569)

    Published 2021
    Save to List
    Saved in:
  10. 50
    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.

    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 51
    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.

    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 52
    Top 20 genes with significantly decreased abundance in Aco<sup>R</sup> cells.

    Top 20 genes with significantly decreased abundance in Aco<sup>R</sup> cells. by Pieter C. Steketee (10024552)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 53
    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session.

    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 54
    Mean ± SD of the different parameters relative to bipedal stance on soft support with the eyes open recorded in the Chewing and Hand Grip groups.

    Mean ± SD of the different parameters relative to bipedal stance on soft support with the eyes open recorded in the Chewing and Hand Grip groups. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 55
    Time course of Path Length, LFS and Velocity during postural training.

    Time course of Path Length, LFS and Velocity during postural training. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 56
    Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training.

    Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 57
    Time course of 95% Area, X and Y Amplitude Sway during postural training.

    Time course of 95% Area, X and Y Amplitude Sway during postural training. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    Correlations between unipedal and bipedal stance parameters recorded at the beginning of the training and of the control session.

    Correlations between unipedal and bipedal stance parameters recorded at the beginning of the training and of the control session. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    Flow diagram.

    Flow diagram. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Significantly changed USSs in the sf3b1 mutants.

    Significantly changed USSs in the sf3b1 mutants. by Bei Zhang (428038)

    Published 2021
    Save to List
    Saved in:

Search Tools: